Can we all just get along? Immunological memory learns tolerance

January 15, 2013 by Chris Defrancesco
Can we all just get along? Immunological memory learns tolerance
In this image from the UConn Health Center immunology researchers’ study, the T cells are depicted in green, while the red indicates dendritic cells, or cells that deliver antigens. Credit: Lefrançois Lab

(Medical Xpress)—Immunology researchers at the University of Connecticut Health Center are learning more about memory T cells, which are cells that fight infection from a previously encountered antigen.

"This work shows that under normal circumstances, memory ignore self-antigens, thereby prohibiting autoimmunity," says Leo Lefrançois, Department of Immunology chair, whose laboratory developed a genetically modified mouse model that made the research possible. "However, when inflammation is introduced the can respond, helping to explain why infections can trigger autoimmune diseases."

Memory T cells normally exist to protect from re-infection. But memory T cells also can cause autoimmune disease when they cross-react with self-antigens, sometimes triggered by infection.

An antigen is a substance normally foreign to the body that evokes an immune response and is bound by T cells. Autoimmunity can occur when T cells bind self-antigens. Co-authors include Evan Jellison, assistant professor of immunology, Lynn Puddington, associate professor of immunology and medicine, former UConn Health Center postdoctoral fellow Michael Turner, and research assistants Elizabeth Lingenheld and Li Zhu. Their work is published in the Dec. 26 issue of the .

"These results have implications for relapsing remitting forms of autoimmune disease as well as for cancer therapy where memory T cells might ignore but could potentially be triggered to attack the tumor," Jellison says.

Explore further: Research describes advantages of new vaccine adjuvant

More information: www.ncbi.nlm.nih.gov/pubmed/23236165

Related Stories

Research describes advantages of new vaccine adjuvant

December 12, 2011

New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest ...

Recommended for you

When liver immune cells turn bad

April 21, 2017

A high-fat diet and obesity turn "hero" virus-fighting liver immune cells "rogue", leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.

Researchers unlock an immunity 'black box'

April 18, 2017

A research team led by St. Jude Children's Research Hospital immunologists has revealed a previously unknown immune machinery that goes awry to trigger the inflammatory disease neutrophilic dermatosis. Neutrophilic dermatoses ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.